Sichuan Yixintang Pharmaceutical Chain Co., Ltd. announced that it will receive CNY 50 million in an equity round of funding on May 28, 2019. The transaction will include participation from the returning investor Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727). The investor will retain its 100% stake after the transaction. Post the closing of the transaction, the company's registered capital will increase from CNY 314 million to CNY 364 million. The transaction was approved by the board of directors in its 14th session of the 4th directorate. The transaction is still subject to approval of the shareholders’ meeting.